KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

基于KIR的抑制性CAR可克服CAR-NK细胞吞噬作用介导的同胞相残和肿瘤逃逸。

阅读:2
作者:Ye Li ,Rafet Basar ,Guohui Wang ,Enli Liu ,Judy S Moyes ,Li Li ,Lucila N Kerbauy ,Nadima Uprety ,Mohsen Fathi ,Ali Rezvan ,Pinaki P Banerjee ,Luis Muniz-Feliciano ,Tamara J Laskowski ,Emily Ensley ,May Daher ,Mayra Shanley ,Mayela Mendt ,Sunil Acharya ,Bin Liu ,Alexander Biederstädt ,Hind Rafei ,Xingliang Guo ,Luciana Melo Garcia ,Paul Lin ,Sonny Ang ,David Marin ,Ken Chen ,Laura Bover ,Richard E Champlin ,Navin Varadarajan ,Elizabeth J Shpall ,Katayoun Rezvani

Abstract

Trogocytosis is an active process that transfers surface material from targeted to effector cells. Using multiple in vivo tumor models and clinical data, we report that chimeric antigen receptor (CAR) activation in natural killer (NK) cells promoted transfer of the CAR cognate antigen from tumor to NK cells, resulting in (1) lower tumor antigen density, thus impairing the ability of CAR-NK cells to engage with their target, and (2) induced self-recognition and continuous CAR-mediated engagement, resulting in fratricide of trogocytic antigen-expressing NK cells (NKTROG+) and NK cell hyporesponsiveness. This phenomenon could be offset by a dual-CAR system incorporating both an activating CAR against the cognate tumor antigen and an NK self-recognizing inhibitory CAR that transferred a 'don't kill me' signal to NK cells upon engagement with their TROG+ siblings. This system prevented trogocytic antigen-mediated fratricide, while sparing activating CAR signaling against the tumor antigen, and resulted in enhanced CAR-NK cell activity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。